Quality of life and its determinants in patients with drug resistant focal epilepsy

Objective: to determine the factors influencing quality of life (QoL) in patients with drug-resistant focal epilepsy (DRFE). Material and methods. 111 adult patients with DRFE were included in the study. Quality of life was measured using the Quality Of Life In Patients with Epilepsy – 31 questionna...

Full description

Bibliographic Details
Main Authors: S. М. Malyshev, Т. М. Alekseeva
Format: Article
Language:Russian
Published: IRBIS LLC 2021-02-01
Series:Эпилепсия и пароксизмальные состояния
Subjects:
Online Access:https://www.epilepsia.su/jour/article/view/623
id doaj-9d213eb3e45b4059b49037078b490334
record_format Article
spelling doaj-9d213eb3e45b4059b49037078b4903342021-07-28T13:43:36ZrusIRBIS LLCЭпилепсия и пароксизмальные состояния2077-83332311-40882021-02-0112421622510.17749/2077-8333/epi.par.con.2020.044504Quality of life and its determinants in patients with drug resistant focal epilepsyS. М. Malyshev0Т. М. Alekseeva1Almazov National Medical Research CentreAlmazov National Medical Research CentreObjective: to determine the factors influencing quality of life (QoL) in patients with drug-resistant focal epilepsy (DRFE). Material and methods. 111 adult patients with DRFE were included in the study. Quality of life was measured using the Quality Of Life In Patients with Epilepsy – 31 questionnaire (QOLIE-31). The severity of the disease (frequency and subjective assessment of the severity of seizures), the effect of pharmacotherapy (drug load and composition of the treatment regimen), the social status of patients, comorbid conditions (anxiety and depressive disorders, pathological fatigue) were assessed. Results. In the studied sample, a pronounced decrease in QoL was shown, the median of the final QOLIE-31 score was 65.4 points (interquartile range 53.0–72.6 points). A statistically significant decrease in QoL was found in subgroups of patients with seizures during the previous three months; taking carbamazepine or benzobarbital; with anxiety and depressive disorders; with pathological fatigue; and in unemployed patients. A multiple linear regression model (R2=0.66) was developed, which included the following determinants: Fatigue Severity Scale, Liverpool Seizure Severity Scale, and the risk of depression according to the NDDI-E questionnaire. Conclusion. In patients with drug-resistant focal epilepsy, there is a pronounced decrease in the quality of life due to combination of factors associated with the characteristics of the disease, treatment, comorbidities, and social status. The key QoL determinants in patients with DRFE are pathological fatigue, anxiety and depression, and subjective severity of epileptic seizures; employment is a positive factor. The role of epileptic seizures frequency in QoL formation in these patients requires further research.https://www.epilepsia.su/jour/article/view/623drug-resistant epilepsyquality of lifedepressionmood disordersfatigue
collection DOAJ
language Russian
format Article
sources DOAJ
author S. М. Malyshev
Т. М. Alekseeva
spellingShingle S. М. Malyshev
Т. М. Alekseeva
Quality of life and its determinants in patients with drug resistant focal epilepsy
Эпилепсия и пароксизмальные состояния
drug-resistant epilepsy
quality of life
depression
mood disorders
fatigue
author_facet S. М. Malyshev
Т. М. Alekseeva
author_sort S. М. Malyshev
title Quality of life and its determinants in patients with drug resistant focal epilepsy
title_short Quality of life and its determinants in patients with drug resistant focal epilepsy
title_full Quality of life and its determinants in patients with drug resistant focal epilepsy
title_fullStr Quality of life and its determinants in patients with drug resistant focal epilepsy
title_full_unstemmed Quality of life and its determinants in patients with drug resistant focal epilepsy
title_sort quality of life and its determinants in patients with drug resistant focal epilepsy
publisher IRBIS LLC
series Эпилепсия и пароксизмальные состояния
issn 2077-8333
2311-4088
publishDate 2021-02-01
description Objective: to determine the factors influencing quality of life (QoL) in patients with drug-resistant focal epilepsy (DRFE). Material and methods. 111 adult patients with DRFE were included in the study. Quality of life was measured using the Quality Of Life In Patients with Epilepsy – 31 questionnaire (QOLIE-31). The severity of the disease (frequency and subjective assessment of the severity of seizures), the effect of pharmacotherapy (drug load and composition of the treatment regimen), the social status of patients, comorbid conditions (anxiety and depressive disorders, pathological fatigue) were assessed. Results. In the studied sample, a pronounced decrease in QoL was shown, the median of the final QOLIE-31 score was 65.4 points (interquartile range 53.0–72.6 points). A statistically significant decrease in QoL was found in subgroups of patients with seizures during the previous three months; taking carbamazepine or benzobarbital; with anxiety and depressive disorders; with pathological fatigue; and in unemployed patients. A multiple linear regression model (R2=0.66) was developed, which included the following determinants: Fatigue Severity Scale, Liverpool Seizure Severity Scale, and the risk of depression according to the NDDI-E questionnaire. Conclusion. In patients with drug-resistant focal epilepsy, there is a pronounced decrease in the quality of life due to combination of factors associated with the characteristics of the disease, treatment, comorbidities, and social status. The key QoL determinants in patients with DRFE are pathological fatigue, anxiety and depression, and subjective severity of epileptic seizures; employment is a positive factor. The role of epileptic seizures frequency in QoL formation in these patients requires further research.
topic drug-resistant epilepsy
quality of life
depression
mood disorders
fatigue
url https://www.epilepsia.su/jour/article/view/623
work_keys_str_mv AT smmalyshev qualityoflifeanditsdeterminantsinpatientswithdrugresistantfocalepilepsy
AT tmalekseeva qualityoflifeanditsdeterminantsinpatientswithdrugresistantfocalepilepsy
_version_ 1721272242746163200